Effect of epicardial adipose tissue in atrial fibrillation

Effect of epicardial adipose tissue in atrial fibrillation - AF and epicardial adipose tissue

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012606

Enrollment

100

Registered

2013-12-17

Start date

2013-12-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Diagnosed as atrial fibrillation by electrocardiogram 2)After catheter ablation therapy for atrial ablation 3)cardiac CT examination before the ablation

Exclusion criteria

Exclusion criteria: 1)moderate or severe valvular disease 2)reduced cardiac function (left ventricular ejection fraction<55%) 3)severe obese cases (BMI>30kg/m2) 4)heart failure cases (BNP>200pg/ml) 5)history of open-heart surgery 6)inflammatory or infection disease cases 7)Patients rejected the use of clinical data

Design outcomes

Primary

Measure	Time frame
recurrence of atrial fibrillation after catheter ablation therapy	—

Secondary

Measure	Time frame
1)distribution, accumulation and property of epicardial adipose tissue 2)blood examination 3)echocardiography	—

Countries

Japan

Contacts

Public ContactTakashi Kusayama

Kanazawa University Hospital Department of Cardiology

ojiichan519@gmail.com090-2838-0612

Outcome results